Find premium company profiles - docstoc

DocStore » Research Reports » Company Profiles

Per Page: 15 25 50

4...

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Transition Therapeutics Inc. (Transition Therapeutics) is a biopharmaceutical company, based in Canada. The company develops medicines for the treatment of Phase II of Alzheimer’s disease and diabetes. It focuses on CNS (Central Nervous Systems) disorders and metabolic diseases. The company product pipeline includes ELND005 and TT223 which are used for the treatment of Alzheimer’s disease and diabetes respectively. Transition Therapeutics provides solutions for disease modifying slowing disease progression and large age related disease indications. The company provides clinical developments services such as advanced treatment for Alzheimer’s disease, preclinical development in CNS indications and preclinical development in diabetes. It has its partners in Ellipsis Neurotherapeutics, NeuroMedix and Anti-glycemic compounds. Transition Therapeutics is headquartered in Toronto, Ontario, Canada.
OncoTherapy Science, Inc. (4564) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

OncoTherapy Science, Inc. (OncoTherapy Science) is a healthcare and biotechnology organization, based in Japan. The company manufactures anti-cancer medicines. OncoTherapy Science’s core technologies to find and manufacture drug candidates are laser micro-beam micro dissection and genome-wide cDNA micro array. It researches on therapies for antibodies, small molecular drugs and RNAi medicines, pepticide vaccines. The company’s product OTS-102, an angiogenesis inhibitor currently in phase I clinical trial for the treatment of metastasis of cancer. It operates through two subsidiaries, Immunas Pharma, Inc. and Laboratories OncoTherapy Science France S.A.R.L. The company affiliates with Mirai Iryo Research Center, Inc. for research and development activities. OncoTherapy Science is headquartered in Kawasaki City, Japan.
PharmswellBio Co., Ltd. (043090) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

PharmswellBio Co., Ltd. (PharmswellBio) is a pharmaceutical and healthcare company, based in Korea. The company manufactures and distributes pharmaceutical raw materials, healthcare products and cosmetics. It provides active pharmaceutical products such as Aceclofenac, Acemetacin, Talniflumate, Teicoplanine, Phenylephrine HCl, Piracetam, Alibendol, Ambroxol HCl, Metformine HCl, Metocarbamol, Minoxidil, Ammonium Glycyrrhizinate Ketoconazole, Ranitidine HCl, Rebamipide, Ketoprofen and Zaltoprofen. PharmswellBio has a research and development division that operates through different areas such as Synthesis R&D lab and Fermentation R&D lab. It provides fermentation production facility for Teicoplanin. The company acquired Ko-Bio Tech. Ko-Bio Tech is a fermentation enterprise. PharmswellBio is headquartered in Seoul, Republic of Korea.
NitroMed, Inc. (NTMD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

NitroMed, Inc. (NitroMed) is a pharmaceutical company that is engaged in discovery, development and commercialization of proprietary pharmaceuticals based on the naturally occurring molecule nitric oxide. The company offers BiDil, a fixed-dose combination of hydralazine hydrochloride and isosorbide dinitrate as its lead product for the treatment of heart failure. The product received the US FDA approval for the treatment of heart failure. NitroMed directly markets BiDil to physicians treating black patients with heart failure. It is engaged further in development of innovative pharmaceutical products in the field of cardiovascular, inflammatory and metabolic diseases for the black population. The company entered in an agreement to sell and license patents and patent applications related to Its Nitric Oxide Technology platform with Deerfield Management. NitroMed is headquartered at Lexington in Massachusetts, the US.
Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Schnell Biopharmaceuticals, Inc. (Schnell) is a publicly held pharmaceutical product manufacturing company. It is engaged in the production of antibiotics, infusions, containing amino acid, vitamin and hepatic protect infusions; gastrointestinal agents, comprising of digestives and antiulcerants; musculoskeletal system agents, consisting of anti-inflammatory drugs, muscle relaxants, respiratory system agents, including expectorants, antitussives and antihistamines. The company also produces vitamins and nutrition agents. It provides the other drugs such as antiemetics and antineoplastic agents. Recently, it has acquired additional stake in CHUNGGEI PHARM, CO., LTD., a pharmaceutical company. SB is headquartered in Seoul, Republic of Korea.
BioPhausia AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

BioPhausia AB (BioPhausia) is a pharmaceutical company, based in Sweden. The company researches, produces and markets pharmaceuticals and biotech firms. Its products include Citodon, Mollipect, Suscard, Lithionit and Laxabon. The company’s other products include in-licensed products, prescription products, OTC products, veterinary products, parallel-imported products and generics. BioPhausia also offers products Digoxin BioPhausia, Egazil, Morfin special, Nitroglycerin BioPhausia, Paraflex, Probecid, Solvezink, Teovent and Theo Dur. The company provides its products to the therapy areas such as psychiatry, pain, respiratory tract, muscle, cardiovascular, inflammation, trauma, minerals and others. It sells and markets its generic products through the subsidiary BMM Pharma. BioPhausia is headquartered Stockholm, Sweden.
Samsung Pharmaceutical Industry Corporation Limited (001360) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Samsung Pharmaceutical Industry Corporation Limited. (SPICO) is a pharmaceutical company, based in Korea. The company develops, manufactures and distributes over the counter pharmaceuticals, prescription pharmaceuticals, healthcare food, healthcare drinks and insecticides. Its OTC products include gastrointestinal drugs, antipyretics, analgesics and anti-inflammatory drugs, dermatologics, hepatic protectors, digestives, cold remedies and cough suppressants. The company offers prescription drugs such as Antihypertensive Drugs, Prokinetic Agents, Antifungal Agents, Antiarrhythmic agents, Vasodilators and Muscle Relaxants. SPICO operates a research and development center for its activities in pharmaceutical efforts and finished tests, microorganism and synthesis of basic raw materials. The company has its K.G.M.P facilities for manufacturing its medicinal products. SPICO is headquartered in Seoul, Korea.
PhytoHealth Corporation (4108) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

PhytoHealth Corporation (PhytoHealth) is a biotechnology company, based in Taiwan. It provides botanical and NCE drug development. The company develops, manufactures and commercializes drugs for the treatment of cerebral vascular diseases, Hepatitis C, motion sickness and osteoporosis. PhytoHealth’s products are classified under four categories that include PCNH, which is used for the prevention and treatment of motion sickness; PG2, which is used for the treatment of marrow depression and generating blood; PH3, used for the treatment of osteoporosis; and PDC-748, which is an analgesic used for the treatment of cough. The company is a member of Maywufa Biopharma Group. It partners with international pharmaceutical companies to develop its products. PhytoHealth is headquartered in Taipei, Taiwan.
TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

TapImmune Inc. (TapImmune) is a biotechnology company, based in the US. The company develops vaccines and therapeutics in the areas of oncology and infectious disease. It has developed TAP vaccine which executes antigens to the surfaces of cells and acts as an adjuvant to improve targeted vaccines against infectious diseases. Taplmmune’s research capabilities and technologies were featured on ABC News BusinessNow, Cancer Research, BusinessWeek, International Journal of Cancer, Journal of Immunology, Nature (Biotechnology), and PLoS Pathogens. The company has acquired three follow-on inventions and IP relating to TAP technology. It has entered into R&D collaboration with Aeras Global TB Vaccine Foundation. Taplummune is headquartered in Seattle, Washington, the US.
Telesso Technologies Limited (TEO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Telesso Technologies Limited (Telesso) is a biotechnology company, based in Australia. The company provides research and development services. It reviews reviewing new business opportunities and focuses on acquisition or in-licensing of late development stage products. Telesso operates through its wholly owned subsidiaries such as, Eiffel Research & Development Pty Ltd, Pharmaceutical Technologies Pty Ltd, Bellara Medical Products Limited, Catsell Pty Limited, Phytochemica Pty Limited, A.C.N. 005 648 966 Pty Limited, A.C.N. 003 330 587 Pty Limited, and Glyzinc Pharmaceuticals Limited, in Australia. The company operates as a subsidiary of VPI Inc, the US. Telesso is headquartered in New South Wales, Australia.
Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Torii Pharmaceutical Co., Ltd. (Torii) is a pharmaceutical company, based in Japan. The company develops, manufactures and distributes pharmaceutical products. Its products include antebate ointment, antebate cream, urinorm tablet, dovonex, ubretid, serotone, futhan, kayexalate and remitch. The company offers products for the treatment of renal diseases, hemodialysis, acute diseases, HIV, skin diseases and lifestyle-related diseases. Its research and development department focuses on implementation of formulations of existed products and development of additional indications. . Torii is ISO 14001 and GMP certified company. The company has collaboration with Japan Tobacco, Inc. Torii is headquartered in Chuo-ku, Tokyo, Japan.
Prima BioMed Limited (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Prima BioMed Limited (Prima) is a biotechnology company, based in Australia. The company develops anti-cancer therapeutics based on the emerging technology of immunotherapy. Its lead products HPV vaccine and CVac is for the development of an ex-vivo immunotherapy for ovarian cancer, cripto-1 focused on the identification of an antibody to tumour cell target and DCtag, used as an adjuvant in cancer and infectious disease vaccines. The company also manufactures mannosylated fusion protein, a critical component to CVac that contains the antigen necessary for the dendritic cells to illicit an immune response against tumor cells. Its products are based on the technologies including dendritic cell therapy, monoclonal antibodies, DCtag adjuvant. Prima is headquartered in Sydney, Australia.
Sawai Pharmaceutical Co., Ltd. (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Sawai Pharmaceutical Co., Ltd. (Sawai Pharmaceutical) is a pharmaceutical company, based in Japan. The company manufactures and sells pharmaceutical products. Its products include drugs for cardiovascular, gastro-intestinal, allergy and chemotherapeutic, antibiotics, blood and body fluid pharmaceutical products, vitamins and others. Sawai Pharmaceutical offers its products in the forms of tablets, capsules, granules, injections, tapes, ophthalmic and nasal solutions, and syrups. The company sells products through the brands such as, HALTHROW OD, LIMARMONE, PRAVATIN, LIPODOWN, ARTIONE, SEFTAC, ITORAT, ALLOZYM, UBIRON and METHYCOOL among others. It operates through its manufacturing units in Kyushu, Sanda, Kanto and Medisa Shinyaku. Sawai Pharmaceutical is headquartered in Osaka, Japan.
Prana Biotechnology Limited (PBT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Prana Biotechnology Limited (Prana Biotechnology) is a pharmaceutical and health care service provider, based in Australia. The company researches and develops therapeutic drugs for neurological diseases. It is focused upon the areas of Alzheimer‘s, Parkinson‘s, and Huntington‘s diseases, as well as various age-related degenerative disorders. The company’s product pipeline includes PBT2 and 4E10 for Alzheimer‘s disease, PBT434 for Parkinson‘s disease, PBT2 for Huntington‘s disease, PBT519 for brain cancer. Its product PBT2 is into preclinical studies and is used to prevent the production of amyloid-ß-peptide (Aß) oligomers, dissolve the existing Aß oligomers, and enhances cognitive function in tg mice. The company operates as subsidiaries of Prana Biotechnology UK Limited and Prana Biotechnology Inc. Prana Biotechnology is headquartered in Victoria, Australia.
SYGNIS Pharma AG (LIOK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

SYGNIS Pharma AG (SYGNIS) is a pharmaceutical company, based in Germany. The company offers research and development of innovative therapies for the treatment of disorders of the central nervous system. It has several projects in preclinical development and late discovery. SYGNIS products include AX200 (Acute Stroke) and KIBRA (Modulators for cognitive enhancement). Its AX200 is a biological molecule, developed for the treatment of neurodegenerative diseases in particular for stroke and is now assessed in a phase II efficacy in ischemic stroke. KIBRA is developed for the improvement of human memory. SYGNIS is headquartered in Heidelberg, Germany.

Per Page: 15 25 50

4...

Company Profiles

Find premium company profile research reports. Purchase and download high quality report analysis, company reports, and much more

DocStore Search:

DocStore » Research Reports » Company Profiles

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

OncoTherapy Science, Inc. (4564) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PharmswellBio Co., Ltd. (043090) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NitroMed, Inc. (NTMD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Schnell Biopharmaceuticals, Inc. (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioPhausia AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Samsung Pharmaceutical Industry Corporation Limited (001360) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PhytoHealth Corporation (4108) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Telesso Technologies Limited (TEO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Prima BioMed Limited (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sawai Pharmaceutical Co., Ltd. (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Prana Biotechnology Limited (PBT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SYGNIS Pharma AG (LIOK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile